Biomarkers & Precision Medicine UK 2025 explores advancements in biomarkers and precision medicine, focusing on regulatory impacts, spatial technologies, and industry lessons learned over the last decade.
Topics
IVDR & LDT Regulations Impact
Business Case for Digital Pathology
Spatial Multi-Omics Needs
Application of Spatial Technologies in Immunology & Oncology
Biomarker Strategies in Pharma
Lessons Learned in Precision Medicine
Who should Attend
Professors
Managing Directors
Lecturers
Senior Scientists
Company Owners
VPs
C-Suite
Executive Scientists
Company Directors
Venue
Queen Elizabeth II Conference Centre (QEII) ,
Broad Sanctuary, Westminster, SW1P 3EE , London, United Kingdom
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.
